iShares Edge MSCI Multifactor Healthcare

Most Recent

  • uploads///Chart  PFE

    Inside Pfizer’s Performance in 3Q17

    PFE stock rose ~7.3% in 3Q17 and has risen ~11.3% YTD (year-to-date) as of October 16.

    By Mike Benson
  • uploads///Chart  RevEPS

    What Pfizer’s Valuation Changes after 2Q17 Tell Us

    Analysts estimate that Pfizer (PFE) stock has the potential to return ~5.9% over the next 12 months.

    By Mike Benson
  • uploads///Chart
    Company & Industry Overviews

    Johnson & Johnson’s Medical Devices Segment in 3Q16

    Johnson & Johnson’s (JNJ) Medical Devices segment grew ~1.1% to ~$6.2 billion for 3Q16 compared to 3Q15.

    By Mike Benson
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.